Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

Cell

Volumn 138, Issue 3, 2009, Pages 592-603

  Shimono, Yohei ^a   Zabala, Maider ^a   Cho, Robert W ^a   Lobo, Neethan ^a   Dalerba, Piero ^a   Qian, Dalong ^a   Diehn, Maximilian ^a   Liu, Huiping ^a   Panula, Sarita P ^a   Chiao, Eric ^a   Dirbas, Frederick M ^b   Somlo, George ^c   Pera, Renee A Reijo ^a   Lao, Kaiqin ^d   Clarke, Michael F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d APPLIED BIOSYSTEMS   (United States)

Author keywords

HUMDISEASE; STEMCELL

Indexed keywords

BMI1 PROTEIN; MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DUCT; CANCER CELL CULTURE; CANCER STEM CELL; CELL EXPANSION; CELL RENEWAL; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYONAL CARCINOMA STEM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MURINAE;

EID: 68049114782     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.07.011     Document Type: Article

References (52)

1. Akala O.O., Park I.K., Qian D., Pihalja M., Becker M.W., and Clarke M.F. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature 453 (2008) 228-232
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
3. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., and Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40 (2008) 499-507
4. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., and Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 35 (2003) 215-217
5. Bruce W.R., and Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199 (1963) 79-80
6. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101 (2004) 2999-3004
7. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353 (2005) 1793-1801
8. Chen J.F., Murchison E.P., Tang R., Callis T.E., Tatsuguchi M., Deng Z., Rojas M., Hammond S.M., Schneider M.D., Selzman C.H., et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 105 (2008) 2111-2116
9. Cho R.W., Wang X., Diehn M., Shedden K., Chen G.Y., Sherlock G., Gurney A., Lewicki J., and Clarke M.F. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26 (2008) 364-371
10. Christoffersen N.R., Silahtaroglu A., Orom U.A., Kauppinen S., and Lund A.H. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 13 (2007) 1172-1178
11. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104 (2007) 10158-10163
12. Daniel V.C., Marchionni L., Hierman J.S., Rhodes J.T., Devereux W.L., Rudin C.M., Yung R., Parmigiani G., Dorsch M., Peacock C.D., et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 69 (2009) 3364-3373
13. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., and Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28 (2008) 4322-4330
14. Eirew P., Stingl J., Raouf A., Turashvili G., Aparicio S., Emerman J.T., and Eaves C.J. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 14 (2008) 1384-1389
15. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
16. Fialkow P.J. Clonal origin of human tumors. Biochim. Biophys. Acta 458 (1976) 283-321
17. Fialkow P.J. Human tumors studied with genetic markers. Birth Defects Orig. Artic. Ser. 12 (1976) 123-132
18. Fialkow P.J. Stem cell origin of human myeloid blood cell neoplasms. Verh. Dtsch. Ges. Pathol. 74 (1990) 43-47
19. Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9 (2008) 102-114
20. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., and Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10 (2008) 593-601
21. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., et al. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
22. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
23. Iwashita T., Kruger G.M., Pardal R., Kiel M.J., and Morrison S.J. Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301 (2003) 972-976
24. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
25. Koralov S.B., Muljo S.A., Galler G.R., Krek A., Chakraborty T., Kanellopoulou C., Jensen K., Cobb B.S., Merkenschlager M., Rajewsky N., et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132 (2008) 860-874
26. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M., and Dick J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 17 (1994) 645-648
27. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
28. Liu R., Wang X., Chen G.Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K., and Clarke M.F. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 356 (2007) 217-226
29. Lobo N.A., Shimono Y., Qian D., and Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23 (2007) 675-699
30. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W., et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 452 (2008) 650-653
31. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
32. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
33. Molofsky A.V., He S., Bydon M., Morrison S.J., and Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19 (2005) 1432-1437
34. Morrison S.J., Qian D., Jerebek L., Thiel B.A., Park I.-K., Ford P.S., Kiel M.J., Schork N.J., Weissman I.L., and Clarke M.F. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 168 (2002) 635-642
35. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
36. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
37. Park S.M., Gaur A.B., Lengyel E., and Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22 (2008) 894-907
38. Pietersen A.M., Evers B., Prasad A.A., Tanger E., Cornelissen-Steijger P., Jonkers J., and van Lohuizen M. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr. Biol. 18 (2008) 1094-1099
39. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104 (2007) 973-978
40. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., and Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 456 (2008) 593-598
41. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
42. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
43. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
44. Stingl J., and Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7 (2007) 791-799
45. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
46. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64 (2004) 3753-3756
47. Tang F., Hajkova P., Barton S.C., O'Carroll D., Lee C., Lao K., and Surani M.A. 220-plex microRNA expression profile of a single cell. Nat. Protocols 1 (2006) 1154-1159
48. Wang Y., Medvid R., Melton C., Jaenisch R., and Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39 (2007) 380-385
49. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., and Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2 (2008) 333-344
50. Wu A.M., Till J.E., Siminovitch L., and McCulloch E.A. Cytological evidence for a relationship between normal hematopoietic colony-forming cells and cells of the lymphoid system. J. Exp. Med. 127 (1968) 455-467
51. Yi R., Poy M.N., Stoffel M., and Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452 (2008) 225-229
52. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., et al. let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123